MobiHealthNews

Dexcom CEO tells investors not to fear new competition from Abbott's Freestyle Libre

Now that the Abbott Freestyle Libre has received FDA clearance, Abbott and Dexcom will be forced into tight competition in the US market. On Dexcom’s third quarter call, CEO Kevin Sayer spent some ...
Medscape

Two 'Wonderful Advances' in CGM: The Dexcom G6 Pro and Libre 2

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...
Forbes

2 Million Patients And Beyond: Abbott’s FreeStyle Libre 2 Cleared In The U.S. For Adults And Children With Diabetes

Pharmaceutical and med device giant Abbott (NYSE: ABT) said today that it had received approval from the Food and Drug Administration (FDA) for its next-generation integrated continuous glucose ...
Reuters

Abbott to hike production of lower-cost glucose monitors as diabetes soars

CHICAGO (Reuters) - Abbott Laboratories plans to ramp up manufacturing capacity for its lower-cost continuous glucose monitor, the FreeStyle Libre, by three to five times in the next few years, aiming ...
MobiHealthNews

Abbott finally gets FDA greenlight for FreeStyle Libre 2

This morning Abbott revealed that its much anticipated integrated continuous glucose monitoring system the FreeStyle Libre 2 is now FDA cleared for adults and kids over the age of 4 with diabetes. The ...